Overview of the Settlement
NYU Langone Health, a prominent academic medical center based in New York City, has reached an $8.5 million settlement with the U.S. Department of Justice. The agreement resolves a federal investigation into allegations that the health system discriminated against transgender patients by denying them access to gender-affirming care.
Details of the Investigation
The investigation was initiated following complaints that NYU Langone had violated Section 1557 of the Affordable Care Act. Federal authorities examined whether the institution's policies and practices effectively barred transgender individuals from receiving medically necessary services that were otherwise available to non-transgender patients. The Department of Justice alleged that these practices constituted unlawful discrimination based on sex.
Terms of the Agreement
Under the terms of the settlement, NYU Langone Health has committed to several corrective actions, including:
- Implementing new non-discrimination policies that explicitly cover gender identity.
- Providing comprehensive training to staff regarding the rights of transgender patients.
- Establishing a monitoring process to ensure ongoing compliance with federal civil rights laws.
Institutional Response
In statements regarding the resolution, representatives for NYU Langone Health emphasized their commitment to providing equitable care to all patients. While the health system did not admit liability as part of the settlement, it stated that it has cooperated fully with the federal inquiry and is dedicated to enhancing its internal protocols to ensure inclusive healthcare delivery moving forward.
0 Comments